(Q73355980)

English

Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tract

scientific article published on 01 November 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tract (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

phase II clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

P H De Mulder

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C Theodore

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Sella

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

O Koriakine

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C N Sternberg

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

L Collette

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C de Balincourt

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 November 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1391-1394

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

The chemotherapy of advanced bladder cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026589120989

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel and carboplatin in bladder cancer: recent developments

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026589120989

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026589120989

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: a Southeastern Cancer Study Group trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026589120989

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026589120989

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026589120989

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026589120989

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026589120989

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026589120989

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026589120989

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Fluorouracil, interferon-alpha-2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study. Hellenic Co-operative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026589120989

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026589120989

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel-based second-line therapy for patients with advanced chemotherapy-resistant bladder carcinoma (M1): a clinical Phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026589120989

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1026589120989

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142477%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73355980&oldid=1752422515"